Mathematical modelling of a hypoxia-regulated oncolytic virus delivered by tumour-associated macrophages
From MaRDI portal
Publication:1716887
DOI10.1016/j.jtbi.2018.10.044zbMath1406.92285OpenAlexW2896620711WikidataQ57804227 ScholiaQ57804227MaRDI QIDQ1716887
Michael A. Boemo, Helen M. Byrne
Publication date: 5 February 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2018.10.044
PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50)
Related Items (4)
A framework for performing data-driven modeling of tumor growth with radiotherapy treatment ⋮ A mixture-like model for tumor-immune system interactions ⋮ Characterizing chemotherapy-induced neutropenia and monocytopenia through mathematical modelling ⋮ Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: a mathematical approach
Cites Work
- Unnamed Item
- A multiphase model describing vascular tumour growth
- Modeling and analysis of a virus that replicates selectively in tumor cells
- A new mathematical model for avascular tumour growth
- The evolution of tumour composition during fractionated radiotherapy: implications for outcome
- Multiphase modelling of vascular tumour growth in two spatial dimensions
- The role of cell-cell interactions in a two-phase model for avascular tumour growth
- Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites
- Macrophage-based anti-cancer therapy: Modelling different modes of tumour targeting
- A mathematical model for cell cycle-specific cancer virotherapy
- Modelling the interactions between tumour cells and a blood vessel in a microenvironment within a vascular tumour
- Modelling the Effect of Cell Shedding on Avascular Tumour Growth
- Modelling solid tumour growth using the theory of mixtures
- Averaged Equations for Two‐Phase Flows
This page was built for publication: Mathematical modelling of a hypoxia-regulated oncolytic virus delivered by tumour-associated macrophages